Oncology

Exposure to carbon may not increase the risk of death among hardmetal workers.

Patients with peripheral neuropathy may experience pain, numbness, and tingling in the hands and feet, despite cessation of chemotherapy.

Limited proportion of patients with chronic hepatitis C virus received antiviral treatment before the widespread use of direct-acting antivirals.

A newly-discovered molecule can induce programmed cell death in mesenchymal-like lung cancer cells.

Certain adjuvant chemotherapy regimens may lead to long-lasting peripheral neuropathy in breast cancer survivors.

Adjuvant endocrine therapy can prevent cancer recurrence but can result in painful side effects.

Top news of the week from Specialty Pharmacy Times.

Wnt signaling activation impacts the response to melanoma treatment.

Mvasi is indicated to treat adult patients with certain types of colorectal, lung, brain, kidney, and cervical cancers.

Sofosbuvir may help improve the kidney function of some patients with hepatitis C virus.

Nerlynx is indicated to treat early-stage HER2-positive breast cancer following trastuzumab-based therapy.

Device may reveal how to stop cancer cells from spreading.

Tumor biology and size should guide breast cancer treatment.

No differences in the effects of screening versus no screening found between 2 prostate cancer trials.

Investigational trastuzumab biosimilar shows promise as potential lower cost treatment option to Herceptin for breast cancer and gastric cancer.

A tissue analyzing pen could revolutionize cancer treatment by improving diagnosis.

A blood cancer drug may kill certain esophageal cancer cells.

Study findings support research demonstrating endoxifen better inhibits tumor growth compared with tamoxifen.

Women with high cholesterol who take statins were 45% less likely to develop breast cancer.

Small node negative tumors can be aggressive, even if classified as clinical low risk.

Mosquito-borne disease attacks and kills glioblastoma stem cells.

Top articles of the week from The American Journal of Pharmacy Benefits.

Manipulating a specific protein could potentially drive tumor cells to self-destruct.

Drug found to slow cyst growth in patients with autosomal dominant polycystic kidney disease.

Determining how hepatitis C progresses is important when considering therapies and the associated costs for different patient groups.

Bruce A. Feinberg, DO, vice president and chief medical officer of Cardinal Health Specialty Solutions, discusses the key elements of an effective cancer clinical care pathways program.

Top news of the day from across the healthcare landscape.

The Department of Veterans Affairs and Bristol-Myers Squibb Foundation seek to increase lung cancer screening among veterans.